Navigation Links
Cocrystal Discovery Receives Awards for Its Novel Antiviral Drug Development Programs
Date:11/3/2010

SEATTLE, Nov. 3, 2010 /PRNewswire/ -- Cocrystal Discovery, Inc., a biopharmaceutical company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and chronic viral diseases, announced today that it has received $733,438 in grants from the Qualified Therapeutic Discovery Project (QTDP) administered under section 48D of the Internal Revenue Code.  The QTDP grant program provides support for innovative projects that are determined by the U.S. Department of Health and Human Services to have reasonable potential to result in a new therapy, reduce health care costs, or significantly advance the goal of curing cancer.

The QTDP grants awarded to Cocrystal are for programs in hepatitis C, influenza, and the common cold, diseases that collectively affect billions of people worldwide.

Cocrystal is a biopharmaceutical company dedicated to the development of small molecule, broad-spectrum antiviral therapeutics. The Company has laboratories in Bothell, Washington and Mountain View, California.  Cocrystal is a privately held company with headquarters in Bothell, Washington.  


'/>"/>
SOURCE Cocrystal Discovery, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
2. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
3. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
4. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
5. ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia
6. Five Clinical Studies to Receive $2.5 Million Under Foundations 2007 Clinical Discovery Program
7. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
8. FASgen Announces New Discovery for Treatment of Stroke
9. Nobel Prize-Winning Discovery
10. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
11. FASgen Announces a New Discovery in Obesity Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... Deutschland und GERMANTOWN, Maryland ... Referenzdatensatz von Horizon bestätigt nachgewiesene ... s   QIAGEN N.V. ... Standard: QIA) gab heute die Ergänzung seines ... und Verifizierungsdaten bekannt, die die bewährte Genauigkeit ...
(Date:5/31/2016)... , Germany and ... -- QIAGEN N.V. (NASDAQ: QGEN ... extensive package consisting of a quality control set and ... System, reinforcing the proven accuracy of its next-generation sequencing ... training for laboratories. QIAGEN has incorporated the Horizon Discovery ...
(Date:5/31/2016)... 31, 2016 Diplomat Pharmacy, Inc. (NYSE: ... conversation slated for June 7, 2016, to take a closer ... noon to 1 p.m. ET, will focus on a man ... the road to wellness. The event is ... patients and health care professionals, talking about triumphs and the ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... , ... Like jewels in a crown, the multiple awards presented to Fayez ... Ontario’s leading day spa and one of Canada’s few accredited 5 Star Spas! ... to combine spa services with hair and beauty services and has resulted ...
(Date:5/31/2016)... ... , ... In his latest video, renowned AstroNumerologist Jesse Kalsi ... presidential candidate Donald Trump as an example, Kalsi describes the way AstroNumerology conveys ... adding numbers up,” says Kalsi. “It is about looking at each individual number, ...
(Date:5/31/2016)... Linda, CA (PRWEB) , ... May 31, 2016 , ... ... both a primary screening tool and as an orthogonal tool for RNAi hit validation. ... highly functional and specific guide RNAs—allows rapid generation of CRISPR RNA (crRNA) collections in ...
(Date:5/31/2016)... ... May 31, 2016 , ... In a recent interview on The Greenburgh ... New Rochelle, NY-based WVOX (1460 AM), leading medical insurance advocate Adria Goldman ... country’s “modern medical money maelstrom.” , During the interview with Mr. Feiner that ...
(Date:5/31/2016)... ... 2016 , ... Advertising Age has recognized SourceLink, ... the tenth consecutive year as a Top 20 Marketing Services Agency. Final results ... eighteenth in the “U.S. CRM/Direct Marketing Agency” category. , Recent investments made ...
Breaking Medicine News(10 mins):